Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000756523 | SCV000884358 | pathogenic | not provided | 2017-12-22 | criteria provided, single submitter | clinical testing | The PKD1 c.8560C>T; p.Gln2854Ter variant is reported in the literature in two families with autosomal dominant polycystic kidney disease (ADPKD) (Audrezet 2012). The variant is absent from the general population databases (1000 Genomes Project, Exome Variant Server, Genome Aggregation Database). The p.Gln2854Ter variant induces an early termination codon and is predicted to result in a truncated protein or mRNA that is subject to nonsense mediated decay. Based on the above information, this variant is considered pathogenic. References: Audrezet MP et al. Autosomal dominant polycystic kidney disease: comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients. Hum Mutat. 2012 Aug;33(8):1239-50. |
Fulgent Genetics, |
RCV002485956 | SCV002776443 | pathogenic | Polycystic kidney disease, adult type | 2021-10-30 | criteria provided, single submitter | clinical testing |